Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update

Critical Reviews in Oral Biology and Medicine

Volumn 13, Issue 1, 2002, Pages 5-16

  Cha, S ^a   Peck, A B ^b   Humphreys Beher, M G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Animal models; Autoimmune exocrinopathy; NOD mice; Pathogenesis; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; MUSCARINIC M3 RECEPTOR;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE EXOCRINOPATHY; B LYMPHOCYTE; DIABETES MELLITUS; GRAFT VERSUS HOST REACTION; HISTOLOGY; HISTOPATHOLOGY; LACRIMAL GLAND; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; T LYMPHOCYTE; XEROSTOMIA;

EID: 0036077727     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130201300103     Document Type: Review

References (122)

1. Major histo-compatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and polymyositis
2. Shuttling of the autoantigen La between nucleus and cell surface after UV irradiation of human keratinocytes
3. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome
4. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors
5. The B1-immunoreactive proteins of the perinatal submandibular gland: Similarity to the major parotid gland protein, RPSP
6. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor
7. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia
8. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptors in patients with Sjögren's syndrome
9. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
10. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy
11. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD IL-4-gene knockout mouse model of Sjögren's syndrome
12. Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice
13. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
14. Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy
15. Respiratory involvement in patients with Sjögren's syndrome: Is it a problem?
16. The role of the insulin-like growth factors in the central nervous system
17. Cytokine-mediated stimulation of laminin expression and cell-growth arrest in a human submandibular gland duct-cell line (HSG)
18. Regulation of tear secretion
19. Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases
20. How can dendritic cells cause autoimmune disease?
21. Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody
22. MHC class I and autoimmune diabetes
23. Pathogenesis of Sjögren's syndrome
24. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome
25. Localization of functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathology
26. Sialoadenitis in experimental graft-versus-host disease. An animal model of Sjögren's syndrome
27. Fas and Fasmediated effects on a human salivary cell line in vitro: A model for immune-mediated exocrine damage in Sjögren's syndrome
28. Sialadenitis in nonobese diabetic mice: Transfer into syngeneic healthy neonates by splenic T lymphocytes
29. Identification of antibodies with muscarinic cholinergic activity in Chagas' disease: Pathological implications
30. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice
31. The histopathology of Sjögren's syndrome in labial salivary gland biopsies
32. Expression of HLA-DR and cytokine genes on interferongamma-stimulated human salivary gland cell line
33. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice
34. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome
35. Autoantibodies to ribonucleoproteins
36. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome
37. Sjögren's syndrome in MRL/l and MRL/n mice
38. Decreased levels of adenylate cyclase contribute to the down-regulation of beta-adrenergic signal transduction in the salivary glands of the non-obese diabetic (NOD) mouse
39. Functional changes in salivary glands of autoimmune disease-prone NOD mice
40. Down regulation of β-adrenergic receptors and signal transduction response in the salivary glands of NOD mice
41. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
42. Characterization of antinuclear antibodies present in the serum from nonobese diabetic (NOD) mice
43. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome
44. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome
45. Acetylcholine acts on M3 muscarinic receptors and induces translocation of aquaporin5 water channel via cytosolic Ca2+ elevation in rat parotid glands
46. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis
47. Murine models of Sjögren's syndrome. Immunohistological analysis of different strains
48. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice
49. Submandibular gland morphogenesis: Stage-specific expression of TGF-alpha/EGF, IGF, TGF-beta, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TGF-beta2, TGF-beta3, and EGF-r null mutations
50. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome
51. Cytokines and growth factors modulate cell growth and insulin-like growth factor binding protein secretion by the human salivary cell line (HSG)
52. Detection of insulin, insulin-like growth factors I and II in saliva and potential synthesis in the salivary glands of mice. Effects of type 1 diabetes mellitus
53. Eye changes in autoimmune NZB and NZBx NZW mice
54. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome
55. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes
56. Thl predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome
57. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome
58. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice
59. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: Involvement of Bax in salivary gland destruction
60. Collagenase in Sjögren's syndrome
61. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome
62. Association of a new allele of the TAP2 gene. TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome
63. Mitochondrial role in life and death of the cell
64. The non-obese diabetic mouse: A model for analyzing the interplay between heredity and environment in development of autoimmune disease
65. Islet cell surface antibodies in juvenile diabetes mellitus
66. Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human neuroma fibroblasts
67. Prevention of insulin dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta chain or normal I-E alpha chain
68. Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels
69. Breeding of a non-obese, diabetic strain of mice
70. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome
71. Overview of classification criteria for SS
72. Sjögren's syndrome salivary gland immunopathology: Increased laminin expression precedes lymphocytic infiltration
73. Autoimmune Sjögren'slike lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides
74. Autoantibodies and their relation to rheumatic diseases
75. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3
76. Tissue specific expression in the salivary glands of transgenic mice
77. Neonatal rat submandibular gland protein SMG-A and parotid secretory protein are alternatively regulated members of a salivary protein multigene family
78. Tear secretion by lacrimal glands in transgenic mice lacking water channels AQP1, AQP3, AQP4 and AQP5
79. Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals
80. Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis
81. Evidence for anti-muscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice
82. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: Additive and hierarchical properties of polygenic inheritance
83. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome
84. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW) F1 mice
85. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome
86. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells
87. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis of NOD mice
88. Expression of parotid secretory protein (PSP) in murine lacrimal glands and its possible function as a bacterial binding protein in exocrine secretions
89. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice
90. Infiltrating lymphocyte populations and cytokine production in the salivary and lacrimal glands of autoimmune NOD mice
91. A novel NOD-derived murine model of primary Sjögren's syndrome
92. null mice reveals a role for autoantibodies in Sjögren's syndrome
93. Defining criteria for autoimmune diseases (Witesky's postulates revisited)
94. Sialadenitis in IQI/Jic mice: A new animal model of Sjögren's syndrome
95. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10
96. Salivary gland ultrasonography in the evaluation of primary Sjögren's syndrome. Comparison with minor salivary gland biopsy
97. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: A single injection has sustained effects on lymphoproliferation and renal disease
98. Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: A phase II clinical trial
99. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
100. Involvement of PARP and poly(ADP)-ribosylation in the early stages of apoptosis and DNA replication
101. Interferon-alpha upregulates gene expression of aquaporin-5 in human parotid glands
102. Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells
103. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice
104. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
105. Murine models of systemic lupus erythematosus
106. The gastrointestinal involvement in primary Sjögren's syndrome
107. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: A spontaneous model for Sjögren's syndrome
108. Two different types of sialoadenitis in the NOD and MRL/lpr mouse models for Sjögren's syndrome: A differential role for dendritic cells in the initiation of sialoadenitis?
109. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation
110. Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells
111. Interleukin-4 deficiency does not exacerbate disease in NOD mice
112. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome
113. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice
114. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line
115. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome
116. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy
117. Age-related alterations in IL-1 beta, TNF-alpha, and IL-6 concentrations in parotid acinar cells from BALB/c and non-obese diabetic mice
118. Alterations in the secretory response of Non-Obese Diabetic (NOD) mice to muscarinic receptor stimulation
119. Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic (NOD) mouse model for autoimmune sialoadenitis
120. Salivary gland cytokine expression in NOD an normal BALB/c mice
121. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice